Kiniksa Pharmaceuticals (KNSA)
NASDAQ:KNSA
US Market
Holding KNSA?
Track your performance easily

Kiniksa Pharmaceuticals (KNSA) Financial Statements

428 Followers

Kiniksa Pharmaceuticals Financial Overview

Kiniksa Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-0.135; its P/E ratio is -168.96; Kiniksa Pharmaceuticals is scheduled to report earnings on February 26, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 112.21M$ 108.63M$ 83.39M$ 67.05M$ 71.47M
Gross Profit$ 92.11M$ 96.31M$ 113.40M$ 57.96M$ 63.77M
EBIT$ -7.20M$ 2.30M-$ -8.50M$ -1.24M
EBITDA$ -6.80M$ 2.44M-$ -7.90M$ 424.00K
Net Income Common Stockholders$ -12.69M$ -3.91M$ 25.24M$ -13.86M$ 28.96M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 223.78M$ 218.76M$ 206.37M$ 201.08M$ 184.99M
Total Assets$ 555.30M$ 542.43M$ 526.32M$ 483.06M$ 484.33M
Total Debt$ 10.60M$ 11.40M$ 12.26M$ 12.96M$ 13.52M
Net Debt$ -213.19M$ -207.36M$ -194.11M$ -188.12M$ -171.47M
Total Liabilities$ 118.29M$ 107.33M$ 87.48M$ 77.94M$ 72.68M
Stockholders Equity$ 437.01M$ 435.09M$ 438.84M$ 405.13M$ 411.66M
Cash Flow-
Free Cash Flow$ -2.24M$ 5.19M-$ 16.97M$ -3.78M
Operating Cash Flow$ -2.24M$ 5.17M$ 4.33M$ 16.99M$ -3.74M
Investing Cash Flow$ -6.35M$ -46.80M$ -14.89M$ -12.28M$ 35.53M
Financing Cash Flow$ 6.69M$ -178.00K$ 695.00K$ 552.00K$ 158.00K
Currency in USD

Kiniksa Pharmaceuticals Earnings and Revenue History

Kiniksa Pharmaceuticals Debt to Assets

Kiniksa Pharmaceuticals Cash Flow

Kiniksa Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis